Clinical Trial Update: An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject [Phase 2]

View source ↗

Summary

A Phase 2 antiviral combination trial in Japanese patients with Hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Infection | Phase 2 | Status: COMPLETED